The smallest, thinnest, high-energy CRT-D in the world
At 9.9 mm thin and only 32.5 cc, the COGNIS CRT-D is a full-featured device, offering improved safety design, enhanced diagnostics, and more flexible programming options—while providing excellent device longevity.
SmartDelay™ AV Optimization
Designed to deliver the accuracy of a pressure catheter without the invasiveness
- In the CRTAVO study, SmartDelay optimization for atrial sensing was 98% correlated to the accurate and reliable invasive pressure measurement LV dP/dtmax. For atrial pacing, the correlation was 96%1
- Designed to recommend an optimal AV delay to maximize LV dP/dtmax in 2.5 minutes or less
- Independently determines paced and sensed AV delays based on three inputs:
- Intrinsic conduction characteristics (sensed and paced AV intervals)
- Interventricular timing
- LV lead location
Atrial Arrhythmia Management
Designed to provide additional support for biventricular pacing during atrial arrhythmias
- Biventricular (BiV) Trigger helps deliver resynchronization therapy as prescribed.
- When used with VRR (Ventricular Rate Regulation), BiV Trigger can increase the percent of ventricular pacing during conducted atrial tachycardias and AF episodes.
Enhanced Cardiac Resynchronization Therapy
Engineered as part of an advanced therapy system to promote the delivery of customized therapy
- Works with a broad portfolio of LV leads designed to provide stability for a wide variety of venous anatomies
- Four LV lead fixation designs have an overall implant success rate of 97%.2
- Expanded Electronic Repositioning™ provides even more options to clinically manage CRT pacing post-implant, including six pacing vectors with a bipolar LV lead and two pacing vectors with a unipolar LV lead
Assurance
Designed with patient safety and reliability in mind
- Designed, built, and tested through Aurora, Boston Scientific Cardiac Rhythm Management’s continuous quality improvement program
- Engineered for safety with rigorously tested self-correcting software and Safety Core™ redundant back-up hardware
The COGNIS CRT-D provides important advances designed to help you give your patients the individualized therapy you expect and they need.
1 CRTAVO data were prospectively collected. However, the data analyses were not prespecified. Refer to Appendix F in the COGNIS System Guide for clinical data on the hemodynamic performance of this feature.
2 ACUITY™ Spiral U.S. clinical study. The ACUITY Spiral success rate with EASYTRAK® family was 97.2%. Data on file.
C8-571
